Literature DB >> 21248132

Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage.

Hartmut B F Pohl1, Cristina Porcheri, Thomas Mueggler, Lukas C Bachmann, Gianvito Martino, Dieter Riethmacher, Robin J M Franklin, Markus Rudin, Ueli Suter.   

Abstract

Loss of oligodendrocytes is a feature of many demyelinating diseases including multiple sclerosis. Here, we have established and characterized a novel model of genetically induced adult oligodendrocyte death. Specific primary loss of adult oligodendrocytes leads to a well defined and highly reproducible course of disease development that can be followed longitudinally by magnetic resonance imaging. Histological and ultrastructural analyses revealed progressive myelin vacuolation, in parallel to disease development that includes motor deficits, tremor, and ataxia. Myelin damage and clearance were associated with induction of oligodendrocyte precursor cell proliferation, albeit with some regional differences. Remyelination was present in the mildly affected corpus callosum. Consequences of acutely induced cell death of adult oligodendrocytes included secondary axonal damage. Microglia were activated in affected areas but without significant influx of B-cells, T-helper cells, or T-cytotoxic cells. Analysis of the model on a RAG-1 (recombination activating gene-1)-deficient background, lacking functional lymphocytes, did not change the observed disease and pathology compared with immune-competent mice. We conclude that this model provides the opportunity to study the consequences of adult oligodendrocyte death in the absence of primary axonal injury and reactive cells of the adaptive immune system. Our results indicate that if the blood-brain barrier is not disrupted, myelin debris is not removed efficiently, remyelination is impaired, and axonal integrity is compromised, likely as the result of myelin detachment. This model will allow the evaluation of strategies aimed at improving remyelination to foster axon protection.

Entities:  

Mesh:

Year:  2011        PMID: 21248132      PMCID: PMC6632929          DOI: 10.1523/JNEUROSCI.5035-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

Review 1.  Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.

Authors:  Arsalan Alizadeh; Soheila Karimi-Abdolrezaee
Journal:  J Physiol       Date:  2016-03-29       Impact factor: 5.182

2.  Central nervous system dysfunction in a mouse model of FA2H deficiency.

Authors:  Kathleen A Potter; Michael J Kern; George Fullbright; Jacek Bielawski; Steven S Scherer; Sabrina W Yum; Jian J Li; Hua Cheng; Xianlin Han; Jagadish Kummetha Venkata; P Akbar Ali Khan; Bärbel Rohrer; Hiroko Hama
Journal:  Glia       Date:  2011-04-13       Impact factor: 7.452

3.  The L-coding region of the DA strain of Theiler's murine encephalomyelitis virus causes dysfunction and death of myelin-synthesizing cells.

Authors:  G D Ghadge; R Wollmann; G Baida; M Traka; R P Roos
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 4.  Oligodendroglia: metabolic supporters of axons.

Authors:  Brett M Morrison; Youngjin Lee; Jeffrey D Rothstein
Journal:  Trends Cell Biol       Date:  2013-08-27       Impact factor: 20.808

5.  Pericyte degeneration causes white matter dysfunction in the mouse central nervous system.

Authors:  Axel Montagne; Angeliki M Nikolakopoulou; Zhen Zhao; Abhay P Sagare; Gabriel Si; Divna Lazic; Samuel R Barnes; Madelaine Daianu; Anita Ramanathan; Ariel Go; Erica J Lawson; Yaoming Wang; William J Mack; Paul M Thompson; Julie A Schneider; Jobin Varkey; Ralf Langen; Eric Mullins; Russell E Jacobs; Berislav V Zlokovic
Journal:  Nat Med       Date:  2018-02-05       Impact factor: 53.440

Review 6.  Myelin regeneration in multiple sclerosis: targeting endogenous stem cells.

Authors:  Jeffrey K Huang; Stephen P J Fancy; Chao Zhao; David H Rowitch; Charles Ffrench-Constant; Robin J M Franklin
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 7.  How histone deacetylases control myelination.

Authors:  Claire Jacob; Frédéric Lebrun-Julien; Ueli Suter
Journal:  Mol Neurobiol       Date:  2011-08-23       Impact factor: 5.590

8.  Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.

Authors:  Andrew V Caprariello; Saisho Mangla; Robert H Miller; Stephen M Selkirk
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

9.  Oligodendrocyte death results in immune-mediated CNS demyelination.

Authors:  Maria Traka; Joseph R Podojil; Derrick P McCarthy; Stephen D Miller; Brian Popko
Journal:  Nat Neurosci       Date:  2015-12-14       Impact factor: 24.884

Review 10.  Remyelination therapy for multiple sclerosis.

Authors:  Michael B Keough; V Wee Yong
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.